adavosertib
Showing 1 - 13 of 13
Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Boston, Houston
Recruiting
- Recurrent Fallopian Tube Carcinoma
- +2 more
- Adavosertib
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 12, 2023
Advanced Solid Tumours Trial in Spain, United Kingdom, United States (Adavosertib)
Active, not recruiting
- Advanced Solid Tumours
- Adavosertib
-
Newnan, Georgia
- +14 more
Mar 15, 2022
Uterine Serous Carcinoma Trial in Worldwide (Adavosertib)
Active, not recruiting
- Uterine Serous Carcinoma
- Adavosertib
-
Burbank, California
- +26 more
Jan 10, 2023
Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation Trial in Canada, Netherlands, United States (Adavosertib, Paclitaxel,
Active, not recruiting
- Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
- Adavosertib
- +4 more
-
Gilbert, Arizona
- +19 more
Aug 23, 2022
CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in
Active, not recruiting
- Central Nervous System Embryonal Tumor With Rhabdoid Features
- +14 more
- Adavosertib
- Irinotecan Hydrochloride
-
Birmingham, Alabama
- +23 more
Oct 7, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Adavosertib)
Active, not recruiting
- Advanced Lymphoma
- +5 more
- Adavosertib
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jun 28, 2022
Advanced Malignant Solid Tumor Trial in United States (Adavosertib, Carboplatin, Everolimus)
Completed
- Advanced Malignant Solid Neoplasm
- Adavosertib
- +5 more
-
Aurora, Colorado
- +7 more
Apr 11, 2022
Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States (Adavosertib)
Suspended
- Advanced Malignant Solid Neoplasm
- Refractory Malignant Solid Neoplasm
- Adavosertib
-
Duarte, California
- +8 more
Mar 15, 2022
Prostate Cancer Trial in Canada (Adavosertib, Savolitinib, Darolutamide)
Recruiting
- Prostate Cancer
- Adavosertib
- +6 more
-
Edmonton, Alberta, Canada
- +10 more
May 9, 2022
Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States
Active, not recruiting
- Ovarian Brenner Tumor
- +11 more
- Adavosertib
- +5 more
-
Duarte, California
- +15 more
Aug 11, 2022
Metastatic Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- +3 more
- Adavosertib
- +5 more
-
Chicago, Illinois
- +4 more
Jun 10, 2021
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022